Effect of Itraconazole and Rifampin on the Pharmacokinetics of Olaparib in Patients With Advanced Solid Tumors: Results of Two Phase I Open-label Studies. (Record no. 26519482)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02050 a2200589 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517121618.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201709s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1879-114X |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/j.clinthera.2016.08.010 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Dirix, Luc |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20170928 |
245 00 - TITLE STATEMENT | |
Title | Effect of Itraconazole and Rifampin on the Pharmacokinetics of Olaparib in Patients With Advanced Solid Tumors: Results of Two Phase I Open-label Studies. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Clinical therapeutics |
Date of publication, distribution, etc. | Oct 2016 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 2286-2299 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged, 80 and over |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Area Under Curve |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cytochrome P-450 CYP3A Inhibitors |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cytochrome P-450 Enzyme System |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Itraconazole |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Phthalazines |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Piperazines |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Rifampin |
General subdivision | administration & dosage |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Swaisland, Helen |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Verheul, Henk M W |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rottey, Sylvie |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Leunen, Karin |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jerusalem, Guy |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rolfo, Christian |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nielsen, Dorte |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Molife, L Rhoda |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kristeleit, Rebecca |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Vos-Geelen, Judith de |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mau-Sørensen, Morten |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Soetekouw, Patricia |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | van Herpen, Carla |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Fielding, Anitra |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | So, Karen |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bannister, Wendy |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Plummer, Ruth |
773 0# - HOST ITEM ENTRY | |
Title | Clinical therapeutics |
Related parts | vol. 38 |
-- | no. 10 |
-- | p. 2286-2299 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.clinthera.2016.08.010">https://doi.org/10.1016/j.clinthera.2016.08.010</a> |
Public note | Available from publisher's website |
No items available.